tiprankstipranks
Trending News
More News >
Syros Pharmaceuticals (SYRS)
:SYRS
US Market

Syros Pharmaceuticals (SYRS) Technical Analysis

Compare
1,080 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
3Neutral
10Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
4Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Syros Pharmaceuticals’s (SYRS) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Syros Pharmaceuticals is a Sell.
Syros Pharmaceuticals’s (SYRS) 20-Day exponential moving average is 0.03, while Syros Pharmaceuticals’s (SYRS) share price is <$0.1, making it a Buy.
Syros Pharmaceuticals’s (SYRS) 50-Day exponential moving average is 0.04, while Syros Pharmaceuticals’s (SYRS) share price is <$0.1, making it a Sell.

Syros Pharmaceuticals (SYRS) Pivot Points

Jun 29, 2025, 05:31 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.02
0.02
0.02
0.03
0.03
0.03
0.04
Fibonacci
0.02
0.02
0.02
0.03
0.03
0.03
0.03
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Syros Pharmaceuticals (SYRS) Moving Averages

Jun 29, 2025, 05:31 PM
Period
Simple
Exponential
MA5
0.03Sell
0.03Buy
MA10
0.03Buy
0.03Buy
MA20
0.02Buy
0.03Buy
MA50
0.03Buy
0.04Sell
MA100
0.06Sell
0.21Sell
MA200
0.58Sell
0.98Sell
Syros Pharmaceuticals’s (SYRS) 10-Day exponential moving average is 0.03, while Syros Pharmaceuticals’s (SYRS) share price is <$0.1, making it a Buy.
Syros Pharmaceuticals’s (SYRS) 100-Day exponential moving average is 0.21, while Syros Pharmaceuticals’s (SYRS) share price is <$0.1, making it a Sell.
Syros Pharmaceuticals’s (SYRS) stock price is <$0.1 and Syros Pharmaceuticals’s (SYRS) 50-day simple moving average is 0.03, creating a Buy signal.
Syros Pharmaceuticals’s (SYRS) stock price is <$0.1 and Syros Pharmaceuticals’s (SYRS) 100-day simple moving average is 0.06, creating a Sell signal.
Syros Pharmaceuticals’s (SYRS) stock price is <$0.1 and Syros Pharmaceuticals’s (SYRS) 200-day simple moving average is 0.58, creating a Sell signal.

Syros Pharmaceuticals (SYRS) Technical Indicators

Jun 29, 2025, 05:31 PM
Name
Value
Implied Action
RSI (14)
54.11
Neutral
STOCH (9,6)
107.41
Sell
STOCHRSI (14)
107.41
Sell
MACD (12,26)
>-0.01
Sell
ADX (14)
15.78
Buy
Williams %R
0.00
Sell
CCI (14)
57.06
Neutral
ATR (14)
<0.01
-
Ultimate Oscillator
69.58
Neutral
ROC
50.00
Buy
Syros Pharmaceuticals’s (SYRS) Relative Strength Index (RSI) is 54.11, creating a Neutral signal.
Syros Pharmaceuticals’s (SYRS) Trend Strength Indicator (ADX) is 15.78, creating a Buy signal.
Syros Pharmaceuticals’s (SYRS) Commodity Channel Index (CCI) is 57.06, creating a Neutral signal.
Syros Pharmaceuticals’s (SYRS) Price Rate of Change (ROC) is 50.00, creating a Buy signal.

FAQ

Is SYRS a Buy, Hold, or Sell?
Based on SYRS’s technical indicators, SYRS is a Hold.
    What is SYRS’s RSI (14)?
    SYRS’s RSI (14) is 54.11, which suggests SYRS is a Neutral.
      What is SYRS’s MACD?
      SYRS’s MACD is >-0.01, which suggests SYRS is a Sell.
        What is SYRS’s 5-day moving average?
        SYRS’s 5-day moving average is 0.03, which suggests SYRS is a Sell.
          What is SYRS’s 20-day moving average?
          SYRS 20-day moving average is 0.02, which suggests SYRS is a Buy.
            What is SYRS’s 50-day moving average?
            SYRS’s 50-day moving average is 0.03, which suggests SYRS is a Buy.
              What is SYRS’s 200-day moving average?
              SYRS’s 200-day moving average is 0.58, which suggests SYRS is a Sell.
                What is SYRS’s Williams % R (14)?
                SYRS’s Williams % R (14) is 0.00, which suggests SYRS is a Sell.
                  What is SYRS’s CCI (14)?
                  SYRS’s CCI (14) is 57.06, which suggests SYRS is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis